Focused radiation for 1 to 5 brain metastases without surgery
Part of Brain & nervous system, Cancer clinical trials.
This Phase 2 study tests a precise, no-head-frame radiation technique to treat brain metastases. It may help by aiming radiation tightly at the tumors while limiting exposure to nearby healthy brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older) with overall ability to function fairly well (ECOG 0 to 2) and expected survival of at least 3 months
- You have a confirmed cancer diagnosis that has spread to the brain, with 1 to 5 brain metastases seen on contrast MRI
- At least one brain tumor is measurable (about 1 cm or larger in one direction), and all tumors are no larger than 3 cm
- You can get a contrast MRI (gadolinium) safely (no allergy and kidney function is adequate, and your device is compatible)
- If you can become pregnant, you must have a negative pregnancy test within 14 days of the scan
- You can understand and agree to sign informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests how to safely give focused radiation (SRS) at different doses to people with brain metastases. It aims to find a dose level that works well while limiting side effects.
This Phase 1 study tests a form of focused radiation given in stages to shrink larger brain metastases. It may help people whose tumors are in the brain but not suited to whole-brain radiation alone, while also checking safety and how well the treatment can be delivered.
This Phase 2 trial tests a type of focused radiation (stereotactic radiosurgery, or SRS) for people with small cell lung cancer that has spread to the brain. It looks at whether this approach can treat brain metastases when the cancer has limited to a certain number of spots.
This trial tests a new approach for people with a single large brain tumor that has spread from another cancer. You would receive a short, focused dose of radiation (stereotactic radiosurgery) in small, separate treatments, followed by surgery to remove the tumor. The goal is to see if this combination works better than the usual treatment.
This trial tests a new way of giving focused radiation (SRS) to larger brain tumors (2 to 5 cm). It aims to safely treat these big tumors without whole-brain radiation, which can have more side effects.
This trial is for people with cancer that has spread to the brain (brain metastases). It tests a new approach where you start a systemic therapy (drugs that travel through your body) and later add focused radiation to the brain tumors, instead of treating them right away. The goal is to see if this sequence works well and avoids unnecessary side effects.
Hear when a new Brain Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.